Don Soland
Director/Miembro de la Junta en DBV TECHNOLOGIES .
Fortuna: 493 695 $ al 31/07/2023
Origen de la red de primer grado Don Soland.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 60 | |
| Public Company | Pharmaceuticals: Major | 40 | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.
27
| Subsidiary | Biotechnology | 27 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.
25
| Subsidiary | Pharmaceuticals: Major | 25 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.
16
| Extinct | Medical Specialties | 16 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
11
| Extinct | Biotechnology | 11 |
| Public Company | Biotechnology | 7 | |
| Public Company | Pharmaceuticals: Major | 6 | |
Viropharma, Inc.
4
| Extinct | 4 | |
Epigenesis Pharmaceuticals LLC
 Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ.
2
| Private Company | Pharmaceuticals: Other | 2 |
| Public Company | Biotechnology | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Don Soland a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| St. Joseph's University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Public Communications Contact Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Operating Officer Chief Operating Officer Corporate Officer/Principal | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities Analyst-Equity | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Operating Officer | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ACERAGEN, INC. | Biotechnology | Chairman Chairman Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| INDIVIOR PLC | Pharmaceuticals: Major | Chairman Chairman Chief Tech/Sci/R&D Officer | |
| IDORSIA LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Director of Finance/CFO President Corporate Officer/Principal | |
| HLS THERAPEUTICS INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| HOOKIPA PHARMA INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| IPSEN | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| LANTHEUS HOLDINGS, INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| VANDA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| LYSOGENE | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| King's College London | College/University | Corporate Officer/Principal Undergraduate Degree | |
| AQUESTIVE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of South Carolina | College/University | Undergraduate Degree Graduate Degree | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Sales & Marketing | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel |
Estadísticas
Internacional
| Estados Unidos | 38 |
| Reino Unido | 5 |
| Francia | 5 |
| Suiza | 3 |
| Canadá | 3 |
Sectorial
| Health Technology | 37 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Finance | 2 |
Operativa
| Director/Board Member | 507 |
| Corporate Officer/Principal | 206 |
| Independent Dir/Board Member | 188 |
| Chairman | 110 |
| Undergraduate Degree | 82 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Torsten Erik Rasmussen | 55 |
| Mark McDade | 35 |
| Paul Brooke | 32 |
| Michel de Rosen | 28 |
| Howard H. Pien | 27 |
| Torbjørn Bjerke | 27 |
| Mary Gray | 27 |
| Laura Brege | 27 |
| Julie McHugh | 26 |
| Charles Rowland | 25 |
| Ferdinand Verdonck | 25 |
| Joseph Feczko | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Timothy Morris | 21 |
- Bolsa de valores
- Insiders
- Don Soland
- Conexiones Empresas
